---
document_datetime: 2023-09-21 19:34:40
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/altargo-epar-all-authorised-presentations_en.pdf
document_name: altargo-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.340931
conversion_datetime: 2025-12-22 07:18:57.517463
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## EMEA Procedure number Invented name Strength Pharmaceutical Form Route of administration Packaging Content Package size

EU/1/07/390/001

EU/1/07/390/002

EU/1/07/390/003

EU/1/07/390/004

Altargo

Altargo

Altargo

Altargo

1%

1%

1%

1%

Ointment

Ointment

Ointment

Ointment

Cutaneous use

Cutaneous use

Cutaneous use

Cutaneous use

Sachet (alu)

Tube (alu)

Tube (alu)

Tube (alu)

0.5g

5g

10g

15g

12 sachets

1 tube

1 tube

1 tube

Medicinal product no longer authorised